Literature DB >> 16438147

Physician adherence to isoniazid preventive therapy guidelines for HIV-infected patients in Thailand.

Narin Hiransuthikul1, Pornthip Hiransuthikul, Kenrad E Nelson, Mayuri Jirawisit, Rawadi Paewplot, Supawan Kasak.   

Abstract

Isoniazid preventive therapy (IPT) has been shown to reduce the risk of active tuberculosis in tuberculin skin test (TST) positive human immunodeficiency virus (HIV) infected individuals. The World Health Organization has recommended IPT for HIV-infected patients since 1999. Physicians' non-adherence to the IPT guideline is one of the limitations to the wide spread use of IPT. A study of the extent to which physicians in Thailand adhere to this guideline will optimize the implementation of national IPT program. Three hundred physicians who provided medical care for HIV-infected patients were sampled by multistage cluster sampling of public hospitals according to the region and the level of health care service. Fifty-eight (19.3%) of the surveyed physicians provided IPT; 86.2% and 34.5% of physicians who provided IPT did not do the TST or screening chest radiography for active TB, respectively. Experience with HIV patient care was significantly associated with providing IPT.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16438147

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme.

Authors:  Salome Charalambous; Alison D Grant; Craig Innes; Christopher J Hoffmann; Rob Dowdeswell; Jan Pienaar; Katherine L Fielding; Gavin J Churchyard
Journal:  AIDS       Date:  2010-11       Impact factor: 4.177

2.  IPT during HIV treatment in Myanmar: high rates of coverage, completion and drug adherence.

Authors:  J Ousley; K P Soe; N T T Kyaw; R Anicete; P E Mon; H Lwin; T Win; S Cristofani; A Telnov; M Fernandez; I Ciglenecki
Journal:  Public Health Action       Date:  2018-03-21

3.  Barriers to tuberculosis and human immunodeficiency virus treatment guidelines adherence among nurses initiating and managing anti-retroviral therapy in KwaZulu-Natal and North West provinces.

Authors:  Lufuno Makhado; Mashudu Davhana-Maselesele; Jason E Farley
Journal:  Curationis       Date:  2018-03-26

4.  Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study.

Authors:  Mesele Mindachew; Amare Deribew; Peter Memiah; Sibhatu Biadgilign
Journal:  Pan Afr Med J       Date:  2014-01-17

5.  Barriers to and motivations for the implementation of a treatment programme for latent tuberculosis infection using isoniazid for people living with HIV, in upper northern Thailand.

Authors:  Saiyud Moolphate; Saranath Lawpoolsri; Petchawan Pungrassami; Natpatou Sanguanwongse; Norio Yamada; Jaranit Kaewkungwal
Journal:  Glob J Health Sci       Date:  2013-03-25

6.  Knowledge and adherence to isoniazid preventive therapy among people living with HIV in multilevel health facilities in South-East, Nigeria: baseline findings from a quasi-experimental study.

Authors:  Ifeyinwa Chizoba Akamike; Ijeoma Nkem Okedo-Alex; Adaoha Pearl Agu; Chihurumnanya Alo; Lawrence Ulu Ogbonnaya
Journal:  Pan Afr Med J       Date:  2020-08-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.